First Republic Investment Management, Inc. Ligand Pharmaceuticals Inc Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$69.53 - $79.33 $44,499 - $50,771	-640 Reduced 18.43%	2,832 $204,000
Q1 2023 May 11, 2023	SELL	$65.67 - $77.08 $9,587 - $11,253	-146 Reduced 4.04%	3,472 $255,000
Q4 2022 Feb 13, 2023	SELL	$61.72 - $96.74 $9,813 - $15,381	-159 Reduced 4.21%	3,618 $241,000
Q3 2022 Nov 03, 2022	BUY	$0.01 - $107.56 $2 - $24,631	229 Added 6.45%	3,777 $325,000
Q2 2022 Aug 16, 2022	SELL	$74.52 - $117.06 $11,028 - $17,324	-148 Reduced 4.0%	3,548 $317,000
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $122,157 - $194,906	-1,286 Reduced 25.81%	3,696 $416,000
Q4 2021 Feb 09, 2022	SELL	$127.69 - $165.85 $45,840 - $59,540	-359 Reduced 6.72%	4,982 $770,000
Q3 2021 Nov 12, 2021	SELL	$102.33 - $144.73 $3,683 - $5,210	-36 Reduced 0.67%	5,341 $744,000
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $11,755 - $16,186	-104 Reduced 1.9%	5,377 $705,000
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $107,183 - $232,448	-1,077 Reduced 16.42%	5,481 $836,000
Q4 2020 Feb 16, 2021	SELL	$80.55 - $106.05 $25,534 - $33,617	-317 Reduced 4.61%	6,558 $652,000
Q3 2020 Nov 12, 2020	SELL	$89.56 - $126.72 $22,121 - $31,299	-247 Reduced 3.47%	6,875 $655,000
Q2 2020 Aug 13, 2020	BUY	$68.28 - $123.65 $4,847 - $8,779	71 Added 1.01%	7,122 $797,000
Q1 2020 May 13, 2020	BUY	$63.37 - $107.88 $93,597 - $159,338	1,477 Added 26.5%	7,051 $513,000
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $7,949 - $9,314	-82 Reduced 1.45%	5,574 $581,000
Q3 2019 Nov 08, 2019	BUY	$86.25 - $120.16 $178,451 - $248,611	2,069 Added 57.68%	5,656 $563,000
Q2 2019 Aug 07, 2019	SELL	$107.38 - $129.34 $5,369 - $6,467	-50 Reduced 1.37%	3,587 $409,000
Q1 2019 Apr 30, 2019	BUY	$105.93 - $142.47 $44,384 - $59,694	419 Added 13.02%	3,637 $457,000
Q4 2018 Feb 12, 2019	BUY	$128.36 - $272.13 $1,797 - $3,809	14 Added 0.44%	3,218 $437,000
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $604,819 - $786,139	-2,864 Reduced 47.2%	3,204 $879,000
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $35,430 - $48,875	235 Added 4.03%	6,068 $1.26 Million
Q1 2018 May 10, 2018	BUY	$138.63 - $182.62 $10,674 - $14,061	77 Added 1.34%	5,833 $963,000
Q4 2017 Feb 09, 2018	SELL	$128.36 - $147.04 $743,589 - $851,802	-5,793 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $700,431 - $799,086	5,793	5,793 $789,000

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account